Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of tivozanib to treat subjects with refractory cancer

Use of tivozanib to treat subjects with refractory cancer

US Patent 11504365 · Granted Nov 22, 2022

Estimated economic value: $9,228,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Batch selection policies for training machine learning models using active learn2025
Assured identity seeder2024
Rating network security posture and comparing network maliciousness2018
Network maliciousness susceptibility analysis and rating2017
Data format for website traffic statistics2013
Network architecture with load balancing, fault tolerance and distributed queryi2012
Method for communication between computing devices using coded values2012
Checkpoint sequence fallout metrics management during path analysis2011
Web usage overlays for third-party web plug-in content2009
Apparatus for determining the relationship of vehicle thrust line, and body cent1986